Medical Devices & Regulation: Flagstaff startup Corvention got FDA clearance for its KardiaPSI balloon catheter, enabling minimally invasive treatment for critically ill U.S. heart valve patients, with a phased rollout focused on training and clinical support. Obesity Drugs: ADA 2026 data on investigational monthly GLP-1 berobenatide (VESPER-1 OLE and VESPER-3) point to meaningful weight loss and a shift from weekly to monthly dosing. Cancer Research Funding: New York earmarked $2M for 9/11 first-responder genomic cancer research at Albert Einstein College of Medicine, aiming to expand testing and earlier detection. Health Tech & Public Health Preparedness: Philadelphia built a mobile disease-testing lab and expanded wastewater monitoring ahead of the FIFA World Cup to speed detection of infections like measles and norovirus. Healthcare Costs & Antitrust: Arizona sued major insurers and cost-management firm Claritev (formerly MultiPlan), alleging a coordinated pricing scheme that suppressed payments to providers. Mental Health & Access: A new clinic expansion in Ontario adds space and clinicians to de-stigmatize mental health care, with continued virtual options. AI & Health Systems: UN-linked reporting warns AI data centers could dramatically increase water use by 2030, raising new sustainability pressure on health-adjacent infrastructure.